Rufinamide, Serum or Plasma
2003176
Ordering Recommendation
Therapeutic drug monitoring.
Mnemonic
RUFIN SP
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Mon-Fri
Reported
1-4 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.  
Collect
Plain red. Also acceptable: Lavender (K2 or K3EDTA), or pink (K2EDTA).  
Specimen Preparation
Separate serum or plasma from cells within 2 hours. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).  
Remarks
  
Stability
After separation from cells: Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks  
Reference Interval
 
 
Therapeutic Range Not well established.
Dose-​related range
(values at dosages of 800-​7200 mg/day)
3-​30 µg/mL
Toxic Not well established
Interpretive Data
Adverse effects may include somnolence, vomiting, headache and fatigue.

See Compliance Statement B: www.aruplab.com/CS  
Note
 
CPT Code(s)
80299
Components
Component Test Code*Component Chart Name
2003177Rufinamide, Serum or Plasma
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Banzel
  • banzel blood level
  • rufinamide blood level